Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy or No Chemotherapy in Clear Margins After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. A Randomised Phase III Trial of Control Vs Capecitabine Plus Oxaliplatin [CHRONICLE]

NCT00427713 is registered in ClinicalTrials.gov with Cancer Research UK as lead sponsor.

NCT NCT00427713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00427713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy or No Chemotherapy in Clear Margins After Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer. A Randomised Phase III Trial of Control Vs Capecitabine Plus Oxaliplatin [CHRONICLE]
Lead sponsor
Cancer Research UK
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
Not reported
Enrollment
800 (estimated)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer